Italia markets open in 4 hours 21 minutes
Dow Jones
32.120,28 +191,66 (+0,60%) Nasdaq
11.434,74 +170,29 (+1,51%) Nikkei 225
26.651,41 -26,39 (-0,10%) EUR/USD
1,0702 +0,0017 (+0,16%) BTC-EUR
27.799,97 -453,73 (-1,61%) CMC Crypto 200
660,13 -10,87 (-1,62%)
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 251,89 |
| Aperto | 253,00 |
| Denaro | 252,00 x 800 |
| Lettera | 252,87 x 800 |
| Min-Max giorno | 250,03 - 254,31 |
| Intervallo di 52 settimane | 198,64 - 258,45 |
| Volume | |
| Media Volume | 3.156.077 |
| Capitalizzazione | 135,158B |
| Beta (5 anni mensile) | 0,58 |
| Rapporto PE (ttm) | 25,00 |
| EPS (ttm) | 10,12 |
| Prossima data utili | 01 ago 2022 - 05 ago 2022 |
| Rendimento e dividendo (forward) | 7,76 (3,08%) |
| Data ex dividendo | 16 mag 2022 |
| Stima target 1A | 249,62 |
- GlobeNewswire
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
NEW YORK and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to welcome the appointment of Jane Gross, Ph.D. to its Board of Directors. Dr. Jane Gross is a highly experienced biotech executive with over 30 years in leading research and development teams f
© 2022 Yahoo. Tutti i diritti riservati.
